Cargando...
Immunotherapy for head and neck squamous cell carcinoma
Over the past years immuno-oncology has evolved and become a novel promising strategy for cancer therapy. Immune checkpoint inhibitors such as pembrolizumab or nivolumab, which target the interaction between programmed death receptor 1/programmed death ligand 1 (PD-1/PDL-1) and PDL-2, have been rece...
Guardado en:
| Publicado en: | Memo |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Vienna
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923082/ https://ncbi.nlm.nih.gov/pubmed/27429658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0270-8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|